IGC Pharma, Inc.

IGC

Exchange: NYSE
Industry: Pharmaceutical Preparations
SEC CIK: 0001326205

SEC filings (opens in a new tab)

No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding IGC Pharma, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of IGC: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Q2 2023	Change
Holders	23	23	0
Shares	2.71M	2.65M	−51.9K (−1.9%)
Value	$917.6K	$827.5K	−$90.1K (−9.8%)

New holders (1)

Institutions that held IGC Pharma, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to IGC in Q2 2023
Institution	Shares	Value	% of portfolio
Two Sigma Securities, LLC	15,444	$4.81K	0.00%

Sold out (1)

Institutions that held IGC Pharma, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of IGC in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Jane Street Group, LLC	15,610	$5.30K